A Study of ABT-072 in Healthy and Hepatitis C Virus Genotype 1-Infected Adults.
Phase of Trial: Phase I
Latest Information Update: 10 Jun 2009
At a glance
- Drugs ABT 072 (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 05 Jun 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
- 05 Jun 2009 Planned number of patients changed from 112 to 100 as reported by ClinicalTrials.gov.
- 05 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.